Resolving sex and gender bias in COVID-19 vaccines R&D and beyond
- PMID: 35143380
- PMCID: PMC9009935
- DOI: 10.1080/21645515.2022.2035142
Resolving sex and gender bias in COVID-19 vaccines R&D and beyond
Abstract
The influence of sex and gender in immune response and vaccine outcomes is established in many disease areas, including in COVID-19. Yet, there are notable gaps in the consideration of sex and gender in the analysis and reporting of COVID-19 vaccines clinical trial data. The push for stronger sex and gender integration in vaccines science should be championed by all researchers and stakeholders across the R&D and access ecosystem - not just gender experts. This requires joint action on the tactical framing of customized value propositions (based on stakeholder motivations), the stronger enforcement of existing regulation, tools, and commitments, and aligning the overall agenda to parallel calls on intersectionality, equity diversity and inclusion.
Keywords: COVID-19; gender; sex; vaccines research.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Similar articles
-
The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.Trials. 2021 Sep 6;22(1):592. doi: 10.1186/s13063-021-05484-2. Trials. 2021. PMID: 34488843 Free PMC article.
-
Biased perceptions against female scientists affect intentions to get vaccinated for COVID-19.Public Underst Sci. 2022 Feb;31(2):239-251. doi: 10.1177/09636625211060472. Epub 2021 Dec 1. Public Underst Sci. 2022. PMID: 34847812
-
Sex-tailored pharmacology and COVID-19: Next steps towards appropriateness and health equity.Pharmacol Res. 2021 Nov;173:105848. doi: 10.1016/j.phrs.2021.105848. Epub 2021 Aug 26. Pharmacol Res. 2021. PMID: 34454035 Free PMC article. Review.
-
Gender, socioeconomic status, and COVID-19 vaccine hesitancy in the US: An intersectionality approach.Sociol Health Illn. 2022 Jun;44(6):953-971. doi: 10.1111/1467-9566.13474. Epub 2022 May 2. Sociol Health Illn. 2022. PMID: 35500003 Free PMC article.
-
The Gender Gap in Brazilian Entomology: an Analysis of the Academic Scenario.Neotrop Entomol. 2021 Dec;50(6):859-872. doi: 10.1007/s13744-021-00918-7. Epub 2021 Nov 12. Neotrop Entomol. 2021. PMID: 34767178 Free PMC article. Review.
Cited by
-
Acting on sex and gender in medical innovation is good for business.BMJ. 2023 Jun 7;381:e072242. doi: 10.1136/bmj-2022-072242. BMJ. 2023. PMID: 37286208 Free PMC article.
-
Undesirable effects of COVID-19 vaccination on Saudi population: A descriptive study, Winter 2022.Int J Health Sci (Qassim). 2024 Jul-Aug;18(4):32-45. Int J Health Sci (Qassim). 2024. PMID: 38974645 Free PMC article.
-
Accuracy of Self-Reported COVID-19 Vaccination Status Compared With a Public Health Vaccination Registry in Québec: Observational Diagnostic Study.JMIR Public Health Surveill. 2023 Jun 16;9:e44465. doi: 10.2196/44465. JMIR Public Health Surveill. 2023. PMID: 37327046 Free PMC article.
-
Pandemic justice for and from Latin America.Ethica. 2023 Mar;22(1):1-25. doi: 10.5007/1677-2954.2023.e97435. Epub 2023 Nov 29. Ethica. 2023. PMID: 38379809 Free PMC article. No abstract available.
-
Measuring National Immunization System Performance: A Systematic Assessment of Available Resources.Glob Health Sci Pract. 2023 Jun 21;11(3):e220055. doi: 10.9745/GHSP-D-22-00555. Print 2023 Jun 21. Glob Health Sci Pract. 2023. PMID: 37348935 Free PMC article. Review.
References
-
- Ursin RL, Klein SL.. Sex differences in respiratory viral pathogenesis and treatments. Annu Rev Virol [Internet]. 2021;8:393–3. [accessed 2021 Jul 2]. https://www.annualreviews.org/doi/10.1146/annurev-virology-091919-092720. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical